首页|黄酮类化合物合成生物体系构建的研究进展

黄酮类化合物合成生物体系构建的研究进展

扫码查看
黄酮是一类广泛存在于植物中的次生代谢产物,具有抗炎、抗癌、抗心血管疾病、抗糖尿病、抗衰老和辐射防护等多种药理活性。目前,黄酮类化合物生产主要依赖于植物提取和化学合成,但难以满足市场需求。因此,采取微生物合成天然产物为其大规模生产提供了新的方法。本文综述了在黄酮类化合物生产中,构建微生物细胞工厂的策略,并整理了近些年通过合成生物学生产黄酮类化合物的相关实例,为黄酮类化合物的合成生物学研究提供参考。
Flavonoids,widely present secondary metabolites found in plants,exhibit a spectrum of pharmacological activities,including anti-inflammatory,anti-cancer,anti-cardiovascular disease,anti-diabetes,anti-aging and radiation protection properties. Currently,the production of flavonoids primarily relies on plant extraction and chemical synthesis,which may not be able to meet the market demand. As a result,microbial synthesis of natural products has emerged as a novel approach for achieving their large-scale production. In the paper,we review the strategies for constructing microbial cell factories in flavonoid production and compile relevant examples of flavonoid production through synthetic biology in recent years,providing a valuable reference for synthetic biology research on flavonoids.

flavonoidbiosynthesiscell factorymetabolic control

王若彤、沈晓凤、严赵玖、孙超、李滢

展开 >

100193 北京,中国医学科学院北京协和医学院药用植物研究所鉴定中心

黄酮类化合物 生物合成 细胞工厂 代谢调控

2024

中国医药生物技术
中国医药生物技术协会

中国医药生物技术

CSTPCD
影响因子:0.368
ISSN:1673-713X
年,卷(期):2024.19(6)